by The cell surface markers detection market involves techniques such as flow cytometry, immunohistochemistry, western blotting that are used for detection and quantification of cell surface markers present on cell membranes. Cell surface markers play a vital role in cellular functions like cell adhesion, cell signalling, immune responses. Flow cytometry has emerged as the most widely used technique for cell surface markers detection owing to its ability to rapidly analyze multiple parameters on individual cells.
The global cell surface markers detection market is estimated to be valued at US$ 6506.69 Mn in 2024 and is expected to exhibit a CAGR of 9.1% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the cell surface markers detection market are Grifols SA, Abbott Laboratories, Sysmex Corporation, Agilent Technologies Inc., Nexcelom Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Nihon Kohden Corporation, F.
Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Becton, Dickinson and Company (BD),
Qiagen NV, Diasorin SpA (Luminex Corporation), Danaher Corporation (Beckman Coulter Inc.), and IVD Medical Holding Limited (Immucor Inc.), among others. The key players are focused on developing novel techniques for cell surface markers detection and expanding their geographical presence worldwide.
Cell Surface Markers Detection Market growth is primarily driven by the global expansion fueled by increasing investment from key players in emerging markets across Asia Pacific and Latin America.The emerging economies provide huge opportunities for market players owing to rising healthcare expenditures, growing prevalence of chronic diseases and rapid modernization of healthcare infrastructure in these regions.
Key opportunities in the cell surface markers detection market include development of kits and reagents for new cell surface markers associated with rare diseases and cancers. There is also a scope for development of portable flow cytometry devices for point-of-care testing applications.
Market drivers
One of the major drivers of cell surface markers detection market is rising adoption of flow cytometry techniques in disease diagnostics and immunophenotyping applications. Flow cytometry allows simultaneous analysis of multiple cell surface markers which helps in accurate disease diagnosis, monitoring treatment responses and disease prognosis. This drives the demand for reagents, kits and instruments required for cell surface markers detection in flow cytometry.
PEST Analysis
Political: The government regulations regarding medical devices and research funding plays a vital role in determining the growth of the cell surface markers detection market. Various regulatory bodies are enforcing strict guidelines to ensure product safety and effectiveness.
Economic: Rising healthcare spends especially in emerging countries will positively influence the market expansion. However, the high costs associated with advanced detection systems poses a challenge.
Social: Increasing prevalence of chronic and infectious diseases have heightened the demand for early diagnosis boosting the adoption of cell surface markers detection technologies. Greater awareness among people about disease management is fueling the market.
Technological: Cell Surface Markers Detection Market Challenges and Opportunities are shaped by recent technological advancements such as flow cytometry, next-generation sequencing, and microarrays, which have made cell surface analysis more efficient and reliable. Developments in biomarker identification and multiplexing capabilities are extending the applications of cell surface markers.
Cell surface markers detection technologies are most prevalent in developed regions like North America and Europe owing to established healthcare systems and availability of advanced diagnostic solutions. The US holds the major share and is likely to continue dominating the market during the forecast period. Asia Pacific is identified as the fastest growing regional market due to rising health awareness, improving access to healthcare facilities, and increasing governmental focus on research and development activities in countries including China, India, and Japan.
In terms of value, Europe is the second largest regional market for cell surface markers detection attributed to increasing R&D investments and early technology adoption. The rising geriatric population and growing incidence of chronic diseases in countries like Germany, France, and the UK are accelerating the uptake of diagnostic technologies. Cell surface biomarkers play an integral role in evaluating diseases like cancer and autoimmune disorders which are commonly occurring health conditions in these nations.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author - Money Singh
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc. LinkedIn Profile
